694 related articles for article (PubMed ID: 33372854)
21. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
23. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.
Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z
Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 papain-like protease plays multiple roles in regulating cellular proteins in the endoplasmic reticulum.
Yang M; Mariano J; Su R; Smith CE; Das S; Gill C; Andresson T; Loncarek J; Tsai YC; Weissman AM
J Biol Chem; 2023 Dec; 299(12):105346. PubMed ID: 37838170
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
Shen S; Guo H; Li Y; Zhang L; Tang Y; Li H; Li X; Wang P-H; Yu X-F; Wei W
J Virol; 2024 Feb; 98(2):e0190923. PubMed ID: 38289118
[TBL] [Abstract][Full Text] [Related]
26. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
Klemm T; Ebert G; Calleja DJ; Allison CC; Richardson LW; Bernardini JP; Lu BG; Kuchel NW; Grohmann C; Shibata Y; Gan ZY; Cooney JP; Doerflinger M; Au AE; Blackmore TR; van der Heden van Noort GJ; Geurink PP; Ovaa H; Newman J; Riboldi-Tunnicliffe A; Czabotar PE; Mitchell JP; Feltham R; Lechtenberg BC; Lowes KN; Dewson G; Pellegrini M; Lessene G; Komander D
EMBO J; 2020 Sep; 39(18):e106275. PubMed ID: 32845033
[TBL] [Abstract][Full Text] [Related]
27. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
Front Immunol; 2022; 13():947272. PubMed ID: 36032116
[TBL] [Abstract][Full Text] [Related]
28. The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity.
Matthews K; Schäfer A; Pham A; Frieman M
Virol J; 2014 Dec; 11():209. PubMed ID: 25481026
[TBL] [Abstract][Full Text] [Related]
29. Insights into the Dynamics and Binding of Two Polyprotein Substrate Cleavage Points in the Context of the SARS-CoV-2 Main and Papain-like Proteases.
Sanusi ZK; Lobb KA
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500348
[TBL] [Abstract][Full Text] [Related]
30. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
[TBL] [Abstract][Full Text] [Related]
31. Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
Huang H; Lei X; Zhao C; Qin Y; Li Y; Zhang X; Li C; Lan T; Zhao B; Sun W; Lu H; Jin N
J Virol; 2024 Feb; 98(2):e0168223. PubMed ID: 38289117
[TBL] [Abstract][Full Text] [Related]
32. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling.
Sun L; Xing Y; Chen X; Zheng Y; Yang Y; Nichols DB; Clementz MA; Banach BS; Li K; Baker SC; Chen Z
PLoS One; 2012; 7(2):e30802. PubMed ID: 22312431
[TBL] [Abstract][Full Text] [Related]
33. Spatial and temporal roles of SARS-CoV PL
Yan S; Wu G
FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
[TBL] [Abstract][Full Text] [Related]
34. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
35. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.
Kumar A; Grams TR; Bloom DC; Toth Z
Viruses; 2022 May; 14(5):. PubMed ID: 35632779
[TBL] [Abstract][Full Text] [Related]
36. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
Zhang S; Wang J; Cheng G
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34452991
[TBL] [Abstract][Full Text] [Related]
37. Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.
Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA
J Mol Graph Model; 2022 Mar; 111():108113. PubMed ID: 34959151
[TBL] [Abstract][Full Text] [Related]
38. The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING.
Cao D; Duan L; Huang B; Xiong Y; Zhang G; Huang H
Sci Signal; 2023 May; 16(783):eadd0082. PubMed ID: 37130168
[TBL] [Abstract][Full Text] [Related]
39. Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.
Wang D; Fang L; Shi Y; Zhang H; Gao L; Peng G; Chen H; Li K; Xiao S
J Virol; 2016 Feb; 90(4):2090-101. PubMed ID: 26656704
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
